At a Glance
| DOI | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 1–2 mg | 100–225 µg |
| Total Duration | 2.5–5 hrs | 3.3–7 hrs |
| Routes | oral | oral |
| Effects | 66 documented | 72 documented |
Dosage
oral
| Level | DOI | 1cP-AL-LAD |
|---|---|---|
| Threshold | 0.5 mg | 20 µg |
| Light | 0.5–1 mg | 50–100 µg |
| Common | 1–2 mg | 100–225 µg |
| Strong | 2–3 mg | 225–350 µg |
| Heavy | 3 mg | 350 µg |
Duration
oral
DOI
oral
Total: 16 hrs – 24 hrsOnset
Come Up
Onset1 hrs – 2 hrs
Come Up1.5 hrs – 3 hrs
1cP-AL-LAD
oral
Total: 7 hrs – 10 hrsPeak
Effects
Safety
Interaction: DOI + 1cP-AL-LAD
No direct interaction data available between these substances. This does not mean the combination is safe.
DOI — Dangerous Interactions
No dangerous interactions recorded.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between DOI and 1cP-AL-LAD?
DOI is classified as a Psychedelic (Substituted amphetamines) while 1cP-AL-LAD is classified as a Psychedelic (Lysergamides). They share 52 effects in common, with 14 effects unique to DOI and 20 unique to 1cP-AL-LAD.
Is it safe to combine DOI and 1cP-AL-LAD?
There is no direct interaction data available for combining DOI and 1cP-AL-LAD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, DOI or 1cP-AL-LAD?
At common doses via oral, DOI is typically dosed at 1–2 mg while 1cP-AL-LAD is dosed at 100–225 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.